Ask the Expert

	Making a marked difference Staf C. Van Cauter, EVP of Bioscan highlights the potential of biomarkers to speed up the drug development process. More >>		Effective disease diagnosis Biomarkers offer the key to the detection and treatment of disease, believes Aurora Sinclair, Scientific Writer with Randox Laboratories Ltd. More >>
	Part of the process Mike Rodd of Bürkert talks about continued collaboration with the pharmaceutical industry and plans for expansion of its facilities. More >>		Ask the expert – QMR Technology In the past, only large pharmaceutical and biotech companies could afford specialised software solutions to track trends and assist growth, but now emerging companies can take advantage of these tools. More >>

Previous Ask the Experts

Ask the expert: Seven questions on…compensation
Nev Skelton of IMS Health answers NGP’s questions about compensation.
More >>

Nuclear imaging drug development tools
NGP asked Staf C. Van Cauter, EVP of Bioscan Inc., how functional molecular imaging helps researchers to distinguish between a drug that fails and a study that fails to test the drug properly.
More >>

Ask the expert: Are you keeping an eye on your products?
NGP asked Dr. Jörg-Peter Conzen, Vice President of Bruker Optics, why Near-Infrared (NIR) spectroscopy is a valuable tool for the pharmaceutical industry.
More >>

Eight Questions on … Key account Management With Nev Skelton, IMS Health
More >>

Ask the expert: the clinical trials questionnaire
With Dr Alex Leigh, VP Head of Clinical Science, Hesperion Ltd
More >>

Ask the expert: Bioinformatics
Simon Smith, Head of Bioinformatics at J&J, on growth and potential breakthroughs
More >>

Ask The Experts: The Consultant
What benefits can a consultancy company really offer? Nick Hughes explains.
More >>

The experts? forum
New screening technologies are allowing the incorporation of ADME/Tox profiling into the earliest phases of the discovery process ? which in turn is facilitating better decision-making in pharmaceutical R&D.
More >>

The stamp of approval
Recent changes have been made to the European Medicines Agency to speed up the process of advice and ensure the efficiency of application assessment ? good news in these times of pandemic panic.
More >>

The content and compliance issue
Kevin O' Leary finds a way through the mess.
More >>

Q&A: Informatics
With Professor Antony N. Davies, Waters Informatics
More >>

Q&A
Dr Reddy?s Laboratories was founded in 1984. Today, it has revenues of US$446 million. NGP finds out how.
More >>